A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 9971 participants.
Also called NCT02099123
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 9,971 participants
- Registry
-
NCT02099123
-
- Other papers using this trial's data
- Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02099123. Randomized; quadruple masking; primary purpose prevention. Start 2015-07 (registry gives no type); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
- Acronym
- STAREE
- Condition
- Independent Living
- Condition
- Disability Free Survival
- Condition
- Elderly
- Condition
- Healthy
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Placebo (for Atorvastatin)
- Lead sponsor
- Monash University
- Collaborator
- National Health and Medical Research Council, Australia
- Collaborator
- National Heart Foundation, Australia
Record details
- Record id
cardio:ct-nct02099123- Content hash
f3e0058196336d465d92f2507153fe36acf6fa8ae2a2b4f5aea0450db2120f7b